|
2181 |
Mastozytose Enthalten in Der Hautarzt Bd. 68, 19.12.2016, Nr. 1, date:1.2017: 67-75
|
|
|
2182 |
Measurements of the trapezius and erector spinae muscles using virtual touch imaging quantification ultrasound-Elastography: a cross section study Enthalten in BMC musculoskeletal disorders Bd. 18, 25.8.2017, Nr. 1, date:12.2017: 1-8
|
|
|
2183 |
Mechanism of ICU-acquired weakness: muscle contractility in critical illness Enthalten in Intensive care medicine Bd. 43, 3.3.2017, Nr. 4, date:4.2017: 584-586
|
|
|
2184 |
Mechanism of New Bone Formation in Axial Spondyloarthritis Enthalten in Current rheumatology reports Bd. 19, 27.7.2017, Nr. 9, date:9.2017: 1-9
|
|
|
2185 |
Mechanistic rationales for targeting interleukin-17A in spondyloarthritis Enthalten in Arthritis Research & Therapy Bd. 19, 8.3.2017, Nr. 1, date:12.2017: 1-9
|
|
|
2186 |
Mechanistic target of rapamycin is necessary for changes in dendritic spine morphology associated with long-term potentiation Enthalten in Molecular brain Bd. 10, 30.10.2017, Nr. 1, date:12.2017: 1-17
|
|
|
2187 |
Median time to low disease activity is shorter in tocilizumab combination therapy with csDMARDs as compared to tocilizumab monotherapy in patients with active rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: sub-analysis of the Swiss and Austrian patients from the ACT-SURE study Enthalten in Clinical rheumatology Bd. 36, 3.8.2017, Nr. 10, date:10.2017: 2187-2192
|
|
|
2188 |
Medication Risk Communication in Rheumatology: Where Are We and Where Do We Go from Here? Enthalten in Current rheumatology reports Bd. 19, 6.2.2017, Nr. 2, date:2.2017: 1-9
|
|
|
2189 |
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates Enthalten in Archives of osteoporosis Bd. 13, 21.12.2017, Nr. 1, date:12.2018: 1-11
|
|
|
2190 |
Medikamentöse Therapie der rheumatoiden Arthritis Enthalten in Der Orthopäde Bd. 28, 1.3.1999, Nr. 2, date:3.1999: 181-188
|
|